Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Renal disease associated with antiretroviral therapy in the treatment of HIV Cooper RD; Tonelli MNephron Clin Pract 2011[]; 118 (3): c262-8The introduction of potent combination antiretroviral therapy (ART) in the treatment of HIV infection has permitted reliable control of disease progression and has markedly improved survival among people with HIV. As a result, health care providers and patients have shifted clinical priorities; whereas once delaying opportunistic illness was a primary focus, increasing emphasis is now placed on preventative health, management of comorbid chronic disease and avoiding long-term toxicities of ART. Although renal disease is common in people with HIV, renal disease specifically due to ART remains relatively rare. Still, as the use of ART continues to increase, health care providers are likely to encounter this potentially serious complication with increasing frequency. Distinguishing ART-related nephrotoxicity from the myriad of other potential causes of renal disease in people with HIV is important in order to avoid unnecessary discontinuation of an appropriate ART regimen. This review focuses on the early recognition of renal disease associated with ART and suggests strategies for management and prevention.|Adenine/adverse effects/analogs & derivatives[MESH]|Anti-Retroviral Agents/*adverse effects[MESH]|Atazanavir Sulfate[MESH]|HIV Infections/*drug therapy[MESH]|Humans[MESH]|Indinavir/adverse effects[MESH]|Kidney Diseases/*chemically induced/diagnosis[MESH]|Oligopeptides/adverse effects[MESH]|Organophosphonates/adverse effects[MESH]|Pyridines/adverse effects[MESH]|Tenofovir[MESH] |
